Multiple ribozyme construct for insertion into CD34+ stem cells: Phase I and II Update

Chiron Corp. (CHIR), Emeryville, Calif.
Ribozyme Pharmaceuticals Inc. (RZYM), Boulder, Colo.

Read the full 122 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE